HOME >> MEDICINE >> NEWS
New study confirms importance of systolic blood pressure

New evidence from the National Heart, Lung, and Blood Institute's Framingham Heart Study finds that systolic blood pressure, far more than diastolic blood pressure, identifies patients with hypertension, determines their blood pressure stage, and indicates the need for treatment, but both measurements used together are best. The study is published in the September issue of Hypertension.

"The message from this study is that you cannot ignore systolic pressure," said Claude Lenfant, M.D., NHLBI Director. "For years, treatment strategies have focused on lowering a patient's diastolic pressure, because diastolic pressure accurately predicted heart disease and stroke risk in younger patients. But this practice excludes the elderly, who tend to have higher systolic pressures and lower diastolic pressures - and who have the least-controlled blood pressure of all patients."

Systolic pressure measures the force blood exerts on the artery walls when the heart beats, and diastolic pressure measures the force on the arteries between heartbeats. Hypertension is diagnosed when the systolic blood pressure is 140 mm Hg or higher or the diastolic blood pressure is 90 mm Hg or higher. Patients are classified into stages of hypertension depending on how high or low their blood pressure is.

There are 50 million adults in the United States with hypertension. Currently, only 68 percent of them are aware of their condition, 54 percent are being treated, and only 27 percent have it under control.

The Framingham researchers examined nearly 5,000 untreated men and women, average age 58, and determined each person's blood pressure stage using both systolic and diastolic pressure together as recommended in the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). NHLBI's National High Blood Pressure Education Program issued the JNC VI guidelines in 1997.

Researchers then compared these
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
16-Sep-1999


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New study confirms importance systolic blood pressure

(Date:5/18/2013)... New York (PRWEB) May 18, 2013 ... mount in courts throughout the country, Bernstein Liebhard LLP ... hip replacement patients often suffer tissue damage before they ... study, which according to Science Daily will appear in ... hip replacement recipients underwent MRI screens of their hips. ...
(Date:5/18/2013)... Although obesity is associated with an ... obesity and esophageal adenocarcinoma, a type of esophageal cancer, ... As reported on Cancer.gov, last reviewed in January ... likely as those of normal and healthy weight to ... and esophageal cancer is not well understood, it is ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, ... Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive ... major market drivers, restraints, and opportunities in North America, ... , 147 market data tables ... 318 pagesand in-depth TOC of “Sleep Apnea ...
(Date:5/18/2013)... Florida (PRWEB) May 18, 2013 Adolescents, ... also known as “Spice” or “K2” are landing in ... helping to curb this drug epidemic with a ... synthetic marijuana. , According to research from the National ... second-most popular illegal drug among American teenagers. In 2012, ...
(Date:5/18/2013)... The Ayurvedic practitioner program will be offered ... West. Program is available in Mexico via Live Internet ... modality practiced for over 5,000 years. In Ayurvedic medicine ... begins when an individual lives in harmony with their ... Ayurveda aims to heal an individual in all levels ...
Breaking Medicine News(10 mins):Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2
(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...
(Date:5/17/2013)... 2013   Shareholder rights attorneys  at Robbins Arroyo ... (NASDAQGS: AVEO) securities has filed a complaint in the ... Massachusetts .  The complaint alleges that Aveo and ... of 1934 (the "Exchange Act") between January 3, 2012 ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) Aveo ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the ...  Sony will be exhibiting and taking orders for this ... the San Diego Convention Center ... May 20 - 22.  The SP6800 ... audio-visual technologies into new and novel functionalities for the ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
Cached News: